glp-1.com How GLP-1 medications are transforming diabetes and weight loss treatment Our Prebiotic Fiber Blend turns everyday foods and drinks into gut healthy GLP-1 Weight System | Prebiotic

Red Flags: Diapason isn't FDA approved, which means there's no guarantee of safety, effectiveness, or even consistency in what's inside the bottle

Matthews JE, Stewart MW, De Boever EH, Dobbins RL, Hodge RJ, Walker SE, et al

In db/db mice, CK treatment increases secondary BAs, such as lithocholic acid (LCA) and deoxycholic acid (DCA) through changes in the gut microbiota, especially the Ruminococcaceae family, and up-regulation of cytochrome P450 family 7 subfamily B member 1 ( Cyp7b1 ) and cytochrome P450 family 27 subfamily A member 1 ( Cyp27a1 ) and down-regulation of cytochrome P450 family 8 subfamily B member 1 ( Cyp8b1 ), which changes BA biosynthesis from the classical pathway to the alternative pathway

35 2030 1,000

For uninsured patients, self-pay options through PlexusDx represent the most financially sustainable path to proven GLP-1 weight loss therapy currently available in the marketplace

Originally developed to treat diabetes, GLP-1 receptor agonists mimic the action of glucagon-like peptide 1, which stimulates insulin production and lowers blood sugar levels